The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. 1999

A Delacourte, and J P David, and N Sergeant, and L Buée, and A Wattez, and P Vermersch, and F Ghozali, and C Fallet-Bianco, and F Pasquier, and F Lebert, and H Petit, and C Di Menza
Unité INSERM 422, Lille, France.

OBJECTIVE To determine the spatiotemporal mapping of neurofibrillary degeneration (NFD) in normal aging and the different stages of AD. BACKGROUND The pathophysiologic significance of AD lesions, namely amyloid plaques and neurofibrillary tangles, is still unclear, especially their interrelationship and their link with cognitive impairment. METHODS The study included 130 patients of various ages and different cognitive statuses, from nondemented control subjects (n = 60, prospective study) to patients with severe definite AD. Paired helical filaments (PHF)-tau and Abeta were used as biochemical and histologic markers of NFD and amyloid plaques, respectively. RESULTS NFD with PHF-tau was systematically present in variable amounts in the hippocampal region of nondemented patients age >75 years. When NFD was found in other brain areas, it was always along a stereotyped, sequential, hierarchical pathway. The progression was categorized into 10 stages according to the brain regions affected: transentorhinal cortex (S1), entorhinal (S2), hippocampus (S3), anterior temporal cortex (S4), inferior temporal cortex (S5), medium temporal cortex (S6), polymodal association areas (prefrontal, parietal inferior, temporal superior) (S7), unimodal areas (S8), primary motor (S9a) or sensory (S9b, S9c) areas, and all neocortical areas (S10). Up to stage 6, the disease could be asymptomatic. In all cases studied here, stage 7 individuals with two polymodal association areas affected by tau pathologic states were cognitively impaired. CONCLUSIONS The relationship between NFD and Alzheimer-type dementia, and the criteria for a biochemical diagnosis of AD, are documented, and an association between AD and the extent of NFD in defined brain areas is shown.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000682 Amyloid A fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease. Amyloid Fibril,Amyloid Fibrils,Amyloid Substance,Fibril, Amyloid,Fibrils, Amyloid,Substance, Amyloid
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings

Related Publications

A Delacourte, and J P David, and N Sergeant, and L Buée, and A Wattez, and P Vermersch, and F Ghozali, and C Fallet-Bianco, and F Pasquier, and F Lebert, and H Petit, and C Di Menza
January 2000, Neurology,
A Delacourte, and J P David, and N Sergeant, and L Buée, and A Wattez, and P Vermersch, and F Ghozali, and C Fallet-Bianco, and F Pasquier, and F Lebert, and H Petit, and C Di Menza
March 1976, Brain : a journal of neurology,
A Delacourte, and J P David, and N Sergeant, and L Buée, and A Wattez, and P Vermersch, and F Ghozali, and C Fallet-Bianco, and F Pasquier, and F Lebert, and H Petit, and C Di Menza
January 1994, Molecular neurobiology,
A Delacourte, and J P David, and N Sergeant, and L Buée, and A Wattez, and P Vermersch, and F Ghozali, and C Fallet-Bianco, and F Pasquier, and F Lebert, and H Petit, and C Di Menza
March 2007, Neurobiology of aging,
A Delacourte, and J P David, and N Sergeant, and L Buée, and A Wattez, and P Vermersch, and F Ghozali, and C Fallet-Bianco, and F Pasquier, and F Lebert, and H Petit, and C Di Menza
August 2010, Biochemical Society transactions,
A Delacourte, and J P David, and N Sergeant, and L Buée, and A Wattez, and P Vermersch, and F Ghozali, and C Fallet-Bianco, and F Pasquier, and F Lebert, and H Petit, and C Di Menza
January 1989, Neurobiology of aging,
A Delacourte, and J P David, and N Sergeant, and L Buée, and A Wattez, and P Vermersch, and F Ghozali, and C Fallet-Bianco, and F Pasquier, and F Lebert, and H Petit, and C Di Menza
January 1994, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
A Delacourte, and J P David, and N Sergeant, and L Buée, and A Wattez, and P Vermersch, and F Ghozali, and C Fallet-Bianco, and F Pasquier, and F Lebert, and H Petit, and C Di Menza
March 1994, Journal of neuropathology and experimental neurology,
A Delacourte, and J P David, and N Sergeant, and L Buée, and A Wattez, and P Vermersch, and F Ghozali, and C Fallet-Bianco, and F Pasquier, and F Lebert, and H Petit, and C Di Menza
June 1993, Medicina clinica,
A Delacourte, and J P David, and N Sergeant, and L Buée, and A Wattez, and P Vermersch, and F Ghozali, and C Fallet-Bianco, and F Pasquier, and F Lebert, and H Petit, and C Di Menza
March 2021, Acta neuropathologica,
Copied contents to your clipboard!